This is a Wegovy news story, published by CNBC, that relates primarily to Sesame news.
For more Wegovy news, you can click here:
more Wegovy newsFor more Sesame news, you can click here:
more Sesame newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CNBC, you can click here:
more news from CNBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
blockbuster obesity drug Wegovy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest diabetes injection Ozempic news, diabetes medications news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
new clinical weight loss programCNBC
•82% Informative
Sesame is adding compounded semaglutide — the active ingredient in Wegovy and Novo Nordisk’s diabetes injection Ozempic — to its platform.
Program could serve as a more affordable alternative for pursuing weight loss, as compounded medications are typically cheaper than their branded counterparts.
Sesame already offers branded weight loss and diabetes drugs through its platform, including through a partnership with Costco .
Sesame 's new program will be live in about two weeks .
Patients will be able to access ongoing consultations via video chat, nutrition, fitness and mindfulness content library.
The content will not be immediately available upon the launch of the new program Wednesday , but Sesame said it will be available in the interim.
"Being able to connect patients who otherwise are struggling with the supply shortage is something we think is worth doing".
VR Score
78
Informative language
75
Neutral language
55
Article tone
informal
Language
English
Language complexity
60
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
7
Source diversity
4
Affiliate links
no affiliate links